Particle.news

Download on the App Store

J&J Commits $2 Billion to 10-Year Fujifilm Deal for North Carolina Biologics Hub

The incumbency advances J&J’s $55 billion U.S. manufacturing plan in response to proposed drug‑import tariffs.

Image
johnsonsss
J&J will use a 160,000ft² manufacturing facility at Fujifilm’s new manufacturing hub in Holly Springs, North Carolina. Credit: PixelBiss via Shutterstock.com.
Image

Overview

  • Johnson & Johnson signed a 10-year incumbency with Fujifilm Biotechnologies to operate a 160,000-square-foot facility at the Holly Springs campus in North Carolina.
  • The commitment totals about $2 billion over the term, and J&J has not disclosed specific product allocations or a detailed startup timeline.
  • The project is expected to add roughly 100 to 120 jobs locally as Fujifilm targets hub operations in 2025 after investing about $3.2 billion.
  • Regeneron previously secured a separate 10-year, $3 billion incumbency at the same site, highlighting the multi-tenant CDMO model for large-scale cell-culture manufacturing.
  • J&J said it will outline additional U.S. facility plans in the coming months, complementing a separate Wilson, North Carolina biologics site announced in 2024.